Abstract
Objective: To measure the acceptance of a coronavirus disease 2019 (COVID-19) vaccine among the sector of the oil company adult population in Kuwait and assess its determinants. Subjects and Methods: A cross-sectional email study enrolled adults working for Kuwait oil companies (n = 1689; aged ≥21 years). Acceptance of a COVID-19 vaccine was considered if participants selected the options and received the vaccine, definitely or probably will accept vaccination against COVID-19 once a vaccine is available.” A modified Poisson regression was used to investigate the associations and calculate the adjusted prevalence ratios (aPRs) and their 95% confidence intervals (CIs). Results: In total, 92.5% (1563/1689) of the participants were willing to accept COVID-19 vaccines once available. No difference in sex was observed in the willingness to accept a COVID-19 vaccine (92.5 vs. 92%, p 0.5). Responders who believed vaccines in general to have health-related risks were less likely to get vaccinated (aPR = 0.39, 95% CI: 0.35 - 0.44). In addition, participants who received the influenza vaccine were more willing to have a COVID-19 vaccine (aPR = 1.44, 95% CI: 1.31 - 1.58). Acceptance of the vaccine against COVID-19 increased as the self-perceived chances of contracting the infection increased (p < 0.001). Conclusion: Overall, 92.5% of the study participants demonstrated a willingness to be vaccinated against COVID-19. However, we found that public health authorities should address several factors influencing the level of acceptance.
Highlights
An outbreak of novel coronavirus in December 2019, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan city China
There was no difference in sex in terms of accepting vaccination against COVID-19 (92.5% vs. 92%, p 0.5; Figure 1)
Overall, 92.5% of the study participants demonstrated a willingness to get vaccinated against COVID-19
Summary
An outbreak of novel coronavirus in December 2019, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan city China. The World Health Organization named the disease coronavirus disease 2019 (COVID-19). The virus caused a cluster of fatal pneumonia cases and rapidly spread worldwide, and subsequently, the WHO declared COVID-19 as a pandemic in March 2020 [1]. Vaccines to prevent SARS-CoV-2 infection are considered the most promising approach for controlling the pandemic and are being vigorously investigated and produced. By the end of 2020, several vaccines had become available for use in different parts of the world [2]. The World Health Organization maintains an updated list of vaccine candidates under evaluation and that given approval [2]. Concerns about safety, loss of trust in vaccine manufacturing, and conspiracy theories surrounding COVID-19 vaccines can be obstacles to vaccine uptake
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
